07-4366. National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Phase I Clinical Trial Units for Therapeutics Against Infectious Diseases.

    Date: September 28, 2007.

    Time: 8 a.m. to 6 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.

    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 3122, 6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-451-3684, bgustafson@niaid.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    August 28, 2007.

    Anna Snouffer,

    Deputy Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 07-4366 Filed 9-6-07; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
9/28/2007
Published:
09/07/2007
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
07-4366
Dates:
September 28, 2007.
Pages:
51460-51460 (1 pages)
PDF File:
07-4366.pdf